SS Innovations revealed the world’s first successful intercontinental robotic cardiac telesurgery, which used its SSi Mantra 3 surgical robotic system.

The company revealed plans to submit SSi Mantra 3 to the U.S. Food and Drug Administration (FDA) in May.

The robotic atrial septal defect closure was performed by SS Innovations chairman and CEO, Dr. Sudhir Srivastava, MD. It was dome remotely from the global headquarters of the Institute of Research Against Digestive Cancer (IRCAD) in Strasbourg, France, during the Society of Robotic Surgery (SRS) annual meeting at a transmission distance of over 4,000 miles to the operating room at the Sri Aurobindo Institute of Medical Sciences (SAIMS) in Indore, India.

The live telesurgery was moderated by robotic cardiac surgeon Dr. Husam H. Balkhy, MD, President of the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) and Professor of Surgery and Director of Robotic and Minimally Invasive Cardiac Surgery at the University of Chicago Medicine. Patient-side support in Indore was coordinated by Dr. Lalit Malik, Chief of Cardiac Surgery, Manipal Hospital, Jaipur; Dr. Ram Krishna Shukla, Cardiologist, SAIMS, Indore; Dr. Bipin Arya, Anesthesiologist, SAIMS, Indore; and the SS Innovations and SAIMS teams.

The team reported successfully completing the surgery without technical issues and with imperceptible latency, flawless precision, and seamless robotic control.

“I would like to extend my gratitude to Dr. Vipul Patel, MD, F.A.C.S., Chairman of the Society of Robotic Surgery for this opportunity at the SRS 2025 Conference, Dr. Mohit Bhandari, the IRCAD India team, and the entire SS Innovations team whose dedication and innovation made the world’s first intercontinental robotic cardiac telesurgery possible,” said Dr. Srivastava. “This historic achievement not only demonstrates the advanced capabilities of our SSi Mantra 3 surgical robotic system but also further paves the way for redefining and democratizing global delivery of complex cardiac care, especially in regions with limited access to surgical expertise.”

To date, the SSi Mantra surgical robot has been used in 35 telesurgeries including 10 cardiac procedures, and a total of 250 cardiac procedures. More than 5,000 multi-specialty surgeries have been carried out using the system without any device-related adverse events.